Brief: Aiforia Expands Its Portfolio Of CE-IVD Marked Clinical Pathology Solutions
April 20 (Reuters) - Aiforia Technologies Oyj AIFORIA.HE :
* AIFORIA EXPANDS ITS PORTFOLIO OF CE-IVD MARKED CLINICAL
PATHOLOGY SOLUTIONS WITH NEW AI MODEL FOR BREAST CANCER
DIAGNOSTICS
* ANNOUNCES CE-IVD MARKING OF AIFORIA® CLINICAL AI MODEL FOR
BREAST CANCER; ER
Source text for Eikon: ID:nWkr1VPM91
Further company coverage: AIFORIA.HE
(Gdansk Newsroom)
((gdansk.newsroom@thomsonreuters.com; +48 58 7696600;))
Recent news on Aiforia Technologies Oyj
See all newsBrief: Aiforia Collaborates with PathAI
Brief: Aiforia Technologies H1 EBITDA Loss €4.73 Mln
Brief: Aiforia And Stratipath Partner To Expand Access To Ai-Driven Precision Diagnostics In Oncology
Brief: Aiforia Technologies To Provide Ai-Assisted Diagnostic Solutions
Brief: Aiforia Technologies Elects Tuomas Tenkanen As Chairman